[Effects of octreotide acetate on intractable chylothorax after surgery for congenital heart diseases].
We experienced 2 infants in whom octreotide acetate was effective on intractable chylothorax after surgery for congenital heart diseases. They were 8- and 5-month-old. They were diagnosed as having corrected transposition of the great arteries (TGA) and tetralogy of Fallot respectively, and underwent bidirectional Glenn anastomosis and right modified Blalock Taussig shunt. Chylothorax was revealed on the 11th and the 1st postoperative day, and was not improved by any conventional therapy in either case. Then octreotide acetate was infused continuously with 0.1-0.6 micorg/kg/hour for 24 and 7 days. Chylothorax disappeared completely without any complications such as disturbance of blood sugar level or growth retardation. Octreotide acetate was effective and safe even in infants in intractable chylothorax after surgery for congenital heart diseases, as long as used for short period.
Kaneko
M
M
Department of Thoracic and Cardiovascular Surgery, Wakayama Medical University, Wakayama, Japan.
Hiramatsu
T
T
Nishimura
Y
Y
Iwahashi
M
M
Komori
S
S
Shibata
M
M
Yuzaki
M
M
Okamura
Y
Y
Suzuki
H
H
Takeuchi
T
T
Shibuta
S
S
D006348:Cardiac Surgical Procedures / Q000379:methods; D002916:Chylothorax / Q000188:drug therapy*; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D007223:Infant; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D011183:Postoperative Complications; D013771:Tetralogy of Fallot / Q000601:surgery; D014188:Transposition of Great Vessels / Q000601:surgery
D015282:Octreotide